GLP1R and type 2 diabetes mellitus: Although previous studies have demonstrated the cardiovascular benefits of GLP-1 RAs [1, 3], our real-world comparison between GLP-1 RAs and DPP4is in patients with comorbid T2D and hypertension did not reveal a statistically significant difference in the primary cardiovascular outcomes.